The mission of the UCSF-Gladstone CFAR is to promote multi-disciplinary HIV research, and the Developmental Core plays a central role. The Developmental Core seeks to accelerate the growth of early-career HIV investigators by providing access to its widely recognized two-year mentoring program, by conducting a robust, peer-reviewed pilot grants program and by promoting assembly of multidisciplinary teams involving both early career and senior investigators to tackle leading-edge questions emerging in HIV research. The Core will continue to advance its heartfelt goals to support emerging leaders in HIV research via 3 specific aims:
Aim 1 : To sustain and refine a comprehensive two-year mentoring program for early career HIV investigators;
Aim 2 : To conduct annual ?Mentoring the Mentors? workshops to train HIV researchers from CFARs around the U.S. in tools and techniques of mentoring;
and Aim 3 : To support innovative research and the development of early stage investigators (ESIs) through four different types of peer-reviewed awards. The Developmental Core's active mentoring program and pilot and supplemental grants program are CFAR's primary vehicles for the support of early career HIV scientists. From 2012-2016, the Developmental Core mentored 69 early career investigators in its formal Mentoring Program and launched the innovative ?Mentoring the Mentors? program to train HIV researchers from around the country in the tools and techniques of effective mentoring. During the same time period, CFAR funded 64 projects with a total amount of $2.6M from its grants program. The Developmental Core helped support 15 supplemental awards for early stage investigators (totaling $3.1M) in a variety of fields, including HIV cure, pre-exposure prophylaxis (PrEP), genomic wide association studies, and implementation science.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027763-29
Application #
9998834
Study Section
Special Emphasis Panel (ZAI1)
Project Start
1997-03-01
Project End
2022-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
29
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Chammartin, Frédérique; Zürcher, Kathrin; Keiser, Olivia et al. (2018) Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis. Clin Infect Dis 67:1643-1652
Pulugulla, Sree H; Packard, Thomas A; Galloway, Nicole L K et al. (2018) Distinct mechanisms regulate IL1B gene transcription in lymphoid CD4 T cells and monocytes. Cytokine 111:373-381
Mohamed, Tamer M A; Ang, Yen-Sin; Radzinsky, Ethan et al. (2018) Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration. Cell 173:104-116.e12
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Vardi, Noam; Chaturvedi, Sonali; Weinberger, Leor S (2018) Feedback-mediated signal conversion promotes viral fitness. Proc Natl Acad Sci U S A 115:E8803-E8810
Carrico, Adam W; Flentje, Annesa; Kober, Kord et al. (2018) Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. Brain Behav Immun 71:108-115
Tymejczyk, Olga; Brazier, Ellen; Yiannoutsos, Constantin et al. (2018) HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. PLoS Med 15:e1002534
Sauceda, John A; Lisha, Nadra E; Neilands, Torsten B et al. (2018) Cognitive-affective depressive symptoms and substance use among Latino and non-Latino White patients in HIV care: an analysis of the CFAR network of integrated clinical systems cohort. J Behav Med :
Carrico, Adam W; Cherenack, Emily M; Roach, Margaret E et al. (2018) Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection. AIDS 32:767-771
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786

Showing the most recent 10 out of 1541 publications